🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

10x Genomics, Inc.

TXG Healthcare
$23.68 $-1 (-4.05%)
Market Cap: $3.01 B
Gurus Holding
7
Popularity Rank
#1192
% of Shares Held
12.24%
Net Activity (Q1 2026)
-$32.91 M

Guru Ownership Trend

Guru Analysis for 10x Genomics, Inc. (TXG)

10x Genomics, Inc. (TXG), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $367.83 M.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $32.91 M net outflow during the quarter.

Recent activity highlights Jefferies Group who increased their stake by 290.2%. Conversely, Ray Dalio reduced exposure by 80.3%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$2.65 M
Total Buy Value
New Buys 1
Additions 2
-$35.56 M
Total Sell Value
Reductions 4
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
4
Net Buyers
3

FAQs for 10x Genomics, Inc. (TXG)

Major holders include Catherine Wood ($248.76 M), Cliff Asness ($53.66 M), Renaissance Technologies (RenTech) ($21.42 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 15.53 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $32.91 M, with 3 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited TXG. The total reported sell value was $35.56 M.

Yes, 1 managers opened new positions in TXG, and 2 increased their existing holdings. The total reported buy value was $2.65 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.93% Reduce -7.5% 11,717,317 $248.76 M Q1 2026
0.02% Reduce -1.6% 2,538,256 $53.66 M Q1 2026
0.03% Reduce -34.9% 1,008,739 $21.42 M Q1 2026
0.01% Add 21.4% 114,953 $2.44 M Q1 2026
0.29% New Buy 63,000 $1.34 M Q1 2026
0.01% Add 290.2% 55,800 $1.18 M Q1 2026
0.00% Reduce -80.3% 35,101 $745,194 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form